You must log in to view this page.

Pelthos Therapeutics Inc. – Filings and Transcripts

NYSE American: PTHS
Share price (3/26/26): $22.74
Market cap (3/26/26): $76.3 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

ended 12/31/24 FY 2024

Prospectuses and Registrations Filter

Prospectus supplement

Shelf registration

Exempt offering of securities

Prospectus supplement

Shelf registration – amended

Ownership Filter

Ikarian Capital, LLC

Einhorn Andrew J.

Einhorn Andrew J.

Ligand Pharmaceuticals Incorporated

News Filter

Announces Fourth Quarter and Full Year 2025 Financial Results

Secures Up to $50 Million Senior Secured Term Loan Facility From Horizon Technology Finance

Investor Presentation

Acquires Xeglyze® (Abametapir) Topical Treatment for Head Lice

Expands Board of Directors With the Appointment of Andrew Einhorn

Proxies Filter

Definitive proxy

Preliminary proxy

Info related to merger

Preliminary info related to merger

Definitive proxy

Other Filter

Notice of effectiveness

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Correspondence with the SEC